SPY312.23+1.71 0.55%
DIA258.42+1.11 0.43%
IXIC10,207.63+53.00 0.52%

UPDATE: Citi Maintains Buy On CVS, Raises Target To $83 'reflecting the solid results and improved sentiment around execution, and we remain optimistic for continued momentum at still discounted valuation levels'

Do you like seeing these details as to why an analyst recommended a stock? What could we do to make this product better? Let us know by emailing newsdesk@benzinga.com

Benzinga · -